Arrivent Biopharma, Inc. Common Stock Stock Forecast
Volatile ride for Arrivent Biopharma, Inc. Common Stock stock price on Wednesday moving between $15.80 and $17.44
(Updated on Jun 26, 2024)
The Arrivent Biopharma, Inc. Common Stock stock price fell by -3.03% on the last day (Wednesday, 26th Jun 2024) from $17.48 to $16.95. It has now fallen 3 days in a row. During the last trading day the stock fluctuated 10.38% from a day low at $15.80 to a day high of $17.44. The price has fallen in 8 of the last 10 days and is down by -9.41% for this period. Volume has increased on the last day by 46 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 95 thousand shares were bought and sold for approximately $1.61 million.
The stock lies in the lower part of a very wide and weak rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $16.48 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 8.90% during the next 3 months and, with a 90% probability hold a price between $17.95 and $22.75 at the end of this 3-month period.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
AVBP Signals & Forecast
There are few to no technical positive signals at the moment. The Arrivent Biopharma, Inc. Common Stock stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $17.56 and $18.57. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Friday, June 21, 2024, and so far it has fallen -5.83%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.
Support, Risk & Stop-loss for Arrivent Biopharma, Inc. Common Stock stock
Arrivent Biopharma, Inc. Common Stock finds support from accumulated volume at $16.80 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $1.64 between high and low, or 10.38%. For the last week, the stock has had daily average volatility of 10.56%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (AVBP) For The Upcoming Trading Day Of Thursday 27th
For the upcoming trading day on Thursday, 27th we expect Arrivent Biopharma, Inc. Common Stock to open at $16.73, and during the day (based on 14 day Average True Range), to move between $15.68 and $18.22, which gives a possible trading interval of +/-$1.27 (+/-7.51%) up or down from last closing price. If Arrivent Biopharma, Inc. Common Stock takes out the full calculated possible swing range there will be an estimated 15.02% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $17.00 (0.29%) than the support at $16.80 (0.88%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is Arrivent Biopharma, Inc. Common Stock stock A Buy?
The Arrivent Biopharma, Inc. Common Stock stock holds several negative signals and despite the positive trend, we believe Arrivent Biopharma, Inc. Common Stock will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.
Current score: -2.244 Sell Candidate Unchanged
Predicted Opening Price for Arrivent Biopharma, Inc. Common Stock of Thursday, June 27, 2024
| Fair opening price June 27, 2024 | Current price |
|---|---|
| $16.73 ( 1.30%) | $16.95 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for AVBP
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 18.37 | 8.38% |
| R2 | 17.74 | 4.68% |
| R1 | 17.36 | 2.40% |
| Price | 16.95 | |
| S1 | 16.10 | -4.99% |
| S2 | 15.72 | -7.28% |
| S3 | 15.09 | -10.97% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 18.31 | 8.02% |
| R2 | 18.00 | 6.19% |
| R1 | 17.00 | 0.295% |
| Price | 16.95 | |
| S1 | 16.80 | -0.88% |
| S2 | 16.04 | -5.37% |
| S3 | 15.50 | -8.55% |
FAQ
Click here for our free guide on how to buy Arrivent Biopharma, Inc. Common Stock Stock.
